Grant: Discovery Grants Program - Individual
University of Western Ontario
$31,000.00
Regulation of Drug Transport Proteins and Drug Metabolizing Enzymes by Nuclear Receptors
FY 2018-19
Summary
Background - The intracellular concentration of chemical molecules determines their activity and toxicity. This applies not only to drugs but also to endogenous molecules such as vitamins and hormones. Membrane transport proteins act as a gateway to determine the concentration available to act on intracellular targets. Intracellular enzymes mediate the metabolism of numerous molecules to detoxify them and/or render them more suitable for elimination. Proteins called nuclear receptors tightly regulate the amount of these transporters and metabolic enzymes. The overall goal of this research program is to further our understanding of the processes that determine the activity of drug transporters and metabolic enzymes. This will help us understand the way the body handles drugs, vitamins and other hormones. *Objectives - The objectives of the proposed research program are to: 1) Investigate the role of a hormone called erythropoietin in mediating the downregulation of metabolic enzymes, 2) To determine the role of intestinal bacteria and the metabolites they produce on transporters and metabolic enzymes, and 3) To determine the impact of nuclear receptor activity on intracellular metabolic pathways. *Scientific Approach Previous studies in our lab determined a hormone made in the kidney called erythropoietin (EPO), significantly decreases expression and activity of an essential metabolic enzyme (CYP3A). To elucidate the mechanism for this effect, we will isolate cells of the liver and treat them with EPO as well as various inhibitors of EPO signalling to determine the mechanism accounting for this effect. *To evaluate the impact of intestinally produced bacterial metabolites on nuclear receptor mediated expression of transporters and metabolic enzymes, we will use germ free mice and antibiotics to alter the intestinal bacterial content. We will then use metabolomic analysis, which allows us to identify and measure the differences in metabolite formation. We will use this technology to determine the changes these treatments induce in target organs such as the intestine, liver and kidney. *Although the contribution of nuclear receptors to regulation of enzymes and transporters is well appreciated in terms of response to drugs, the endogenous biological role of these processes is unknown. We will use established nuclear receptor knockout mouse models of two of important nuclear receptors (e.g. Pxr and Car) to perform genomic and metabolomic analysis in order to identify novel pathways regulated by these essential proteins. *Expected Significance The findings from this program of research will elucidate the mechanisms associated with modulation in gene expression of membrane transport proteins and metabolic enzymes at the molecular level. Ultimately these investigations will help us understand how the body handles and processes exogenous and endogenous compounds.*
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2016-05056
Name nom
Urquhart, Bradley
Department département
Physiology and Pharmacology
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2016
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5101
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Absorption and transport
Research subject fr
Absorption et transport
Partie
3
Nb partie
5
Application title
Regulation of Drug Transport Proteins and Drug Metabolizing Enzymes by Nuclear Receptors
Keyword
NSERC
Application summary
Background - The intracellular concentration of chemical molecules determines their activity and toxicity. This applies not only to drugs but also to endogenous molecules such as vitamins and hormones. Membrane transport proteins act as a gateway to determine the concentration available to act on intracellular targets. Intracellular enzymes mediate the metabolism of numerous molecules to detoxify them and/or render them more suitable for elimination. Proteins called nuclear receptors tightly regulate the amount of these transporters and metabolic enzymes. The overall goal of this research program is to further our understanding of the processes that determine the activity of drug transporters and metabolic enzymes. This will help us understand the way the body handles drugs, vitamins and other hormones. *Objectives - The objectives of the proposed research program are to: 1) Investigate the role of a hormone called erythropoietin in mediating the downregulation of metabolic enzymes, 2) To determine the role of intestinal bacteria and the metabolites they produce on transporters and metabolic enzymes, and 3) To determine the impact of nuclear receptor activity on intracellular metabolic pathways. *Scientific Approach Previous studies in our lab determined a hormone made in the kidney called erythropoietin (EPO), significantly decreases expression and activity of an essential metabolic enzyme (CYP3A). To elucidate the mechanism for this effect, we will isolate cells of the liver and treat them with EPO as well as various inhibitors of EPO signalling to determine the mechanism accounting for this effect. *To evaluate the impact of intestinally produced bacterial metabolites on nuclear receptor mediated expression of transporters and metabolic enzymes, we will use germ free mice and antibiotics to alter the intestinal bacterial content. We will then use metabolomic analysis, which allows us to identify and measure the differences in metabolite formation. We will use this technology to determine the changes these treatments induce in target organs such as the intestine, liver and kidney. *Although the contribution of nuclear receptors to regulation of enzymes and transporters is well appreciated in terms of response to drugs, the endogenous biological role of these processes is unknown. We will use established nuclear receptor knockout mouse models of two of important nuclear receptors (e.g. Pxr and Car) to perform genomic and metabolomic analysis in order to identify novel pathways regulated by these essential proteins. *Expected Significance The findings from this program of research will elucidate the mechanisms associated with modulation in gene expression of membrane transport proteins and metabolic enzymes at the molecular level. Ultimately these investigations will help us understand how the body handles and processes exogenous and endogenous compounds.*